Literature DB >> 32941627

The re-emergence of Zika in Brazil in 2020: a case of Guillain Barré Syndrome during the low season for arboviral infections.

Kevan M Akrami1,2,3, Betania Mara Freitas de Nogueira1,2, Mateus Santana do Rosário1, Laise de Moraes1, Marli Tenório Cordeiro4, Rodrigo Haddad5, Lillian Nunes Gomes1, Isabele de Pádua Carvalho1, Ellen Dos Reis Pimentel1, Jéssica de Jesus Silva1, Marcos Vinícius Lima de Oliveira Francisco1, Isadora Cristina de Siqueira1, Daniel Farias6, Manoel Barral-Netto1, Aldina Barral1, Viviane Boaventura1,2, Ricardo Khouri1,2.   

Abstract

Entities:  

Keywords:  Flavivirus; Zika vaccines; chikungunya; congenital Zika syndrome; dengue; public health emergency of international concern

Mesh:

Year:  2020        PMID: 32941627      PMCID: PMC7649381          DOI: 10.1093/jtm/taaa165

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


× No keyword cloud information.

Report

Since emergence in Brazil in 2015, manifestations of Zika virus (ZIKV) infections range from asymptomatic to severe neurological complications, including Guillain Barré Syndrome (GBS) in adults and microcephaly in newborns via transplacental transmission., In 2015, a 4-fold increase in adult ZIKV infections was reported characterized by GBS cases with frequency similar to the 2013 French Polynesian ZIKV outbreak. Brazilian ZIKV infections fell from 2016 to 2019, suggesting that most susceptible individuals were infected during the initial epidemic, though animal reservoirs persist. Chikungunya virus (CHIKV) emerged in Brazil as another arbovirus associated with GBS. Here, we present a GBS case in northeastern Brazil outside the typical arboviral season. As the rainy season ended, a 29-year-old man presented with 2 days of ascending paresthesia in feet, then paraparesis of lower extremities. Neurologic symptoms evolved to his trunk and upper extremities associated with respiratory distress, urinary incontinence and dysphagia. Eight days prior, he noted myalgia and fever without rash, conjunctivitis, retro-orbital pain or diarrhea. He did not recall mosquito exposure; however, reported no regular use of repellent or screened windows. The rural area where he lived was affected during the ZIKV epidemic in 2015–16, with an incidence of over 300 cases per 100 000 inhabitants. In the neurologic intensive care unit 48 hours after symptom onset, patient examination revealed dyspnea, proximal and distal sensory loss, tetraplegia and dysarthria with facial symmetry requiring mechanical ventilation. Laboratory results noted leukocytosis 13 600 mm3 (normal range: 3600–11 000 mm3) and erythrocyte sedimentation rate 59 mm/h (normal < 15 mm/h). Cerebrospinal fluid analyses were within normal range. At Day 33 from symptom onset, RT-qPCR of plasma, urine and oral swabs for ZIKV, DENV and CHIKV were negative (Supplemental Table 1). Serology for ZIKV (IgM, IgG, PRNT) was positive, negative for DENV (NS1, IgM, PRNT) and negative for CHIKV by IgG and PRNT (though positive IgM) (Supplemental Tables 2 and 3). No improvement in neurologic function occurred following intravenous immunoglobulin (IVIg, 40 g/day) initiated on Day 5 after symptom onset. Neurologic examination at discharge (Day 45) demonstrated 1 of 5 strength in lower extremities and 3 of 4 in upper extremities with bilateral areflexia and diminished general tactile sensation. Electromyography at Day 115 revealed motor and sensory polyradiculopathy, demyelination with re-innervation of right upper extremity muscles though ongoing active denervation bilaterally in lower extremities. By Day 195, he remained with diminished sensation and strength in the feet requiring a walker to ambulate. Despite early IVIg therapy, he remained severely impaired 6 months after disease onset. Long-term sequelae occur in up to 20% of ZIKV-GBS with ambulation disability lasting up to 1 year. Lack of an exhaustive search for alternative causes of GBS is a possible limitation, though his symptoms and laboratory findings were most consistent with arbovirus associated GBS. Previous work during ZIKV and CHIKV-outbreaks in Brazil noted an association with GBS, a relationship other studies in Central and South America also found. This ZIKV- and CHIKV-associated GBS case highlights the ongoing importance of vigilance in residents and travelers to regions with prior ZIKV and CHIKV outbreaks, particularly outside typical arboviral seasons.

Authors’ contribution

Conceived and designed the study: Ricardo Khouri, Viviane Boaventura, Kevan Michal Akrami and Betania Mara Freitas de Nogueira. Performed clinical evaluation: Kevan Michal Akrami, Betania Mara Freitas de Nogueira, Viviane Boaventura, Mateus Santana do Rosário, Isadora Cristina de Siqueira and Daniel Farias. Performed the experiments: Laíse de Moraes, Marli Tenório, Lillian Nunes Gomes, Isabele de Pádua Carvalho, Ellen dos Reis Pimentel, Jéssica de Jesus Silva and Marcos Vinícius Lima de Oliveira Francisco. Analyzed the data: Ricardo Khouri, Viviane Boaventura and Kevan Michal Akrami. Wrote the paper: Ricardo Khouri, Viviane Boaventura and Kevan Michal Akrami. Supervised the project: Ricardo Khouri, Viviane Boaventura, Manoel Barral Netto and Aldina Barral. All authors provided critical feedback and helped shape the manuscritpt.

Funding

This work was financed in part by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, 439967/2016-3) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES, finance code 001). None of the funding organizations had any role in the study design, data collection, data interpretation or writing of this report.

Conflict of interest

All authors have disclosed no potential conflicts of interest. Click here for additional data file.
  5 in total

Review 1.  Guillain-Barré syndrome associated with the Zika virus outbreak in Brazil.

Authors:  Lucas Masiêro Araujo; Maria Lucia Brito Ferreira; Osvaldo Jm Nascimento
Journal:  Arq Neuropsiquiatr       Date:  2016-03       Impact factor: 1.420

2.  Zika Virus Associated with Microcephaly.

Authors:  Jernej Mlakar; Misa Korva; Nataša Tul; Mara Popović; Mateja Poljšak-Prijatelj; Jerica Mraz; Marko Kolenc; Katarina Resman Rus; Tina Vesnaver Vipotnik; Vesna Fabjan Vodušek; Alenka Vizjak; Jože Pižem; Miroslav Petrovec; Tatjana Avšič Županc
Journal:  N Engl J Med       Date:  2016-02-10       Impact factor: 91.245

3.  The spectrum of neurological disease associated with Zika and chikungunya viruses in adults in Rio de Janeiro, Brazil: A case series.

Authors:  Ravi Mehta; Cristiane Nascimento Soares; Raquel Medialdea-Carrera; Mark Ellul; Marcus Tulius Texeira da Silva; Anna Rosala-Hallas; Marcia Rodrigues Jardim; Girvan Burnside; Luciana Pamplona; Maneesh Bhojak; Radhika Manohar; Gabriel Amorelli Medeiros da Silva; Marcus Vinicius Adriano; Patricia Brasil; Rita Maria Ribeiro Nogueira; Carolina Cardoso Dos Santos; Lance Turtle; Patricia Carvalho de Sequeira; David W Brown; Michael J Griffiths; Ana Maria Bispo de Filippis; Tom Solomon
Journal:  PLoS Negl Trop Dis       Date:  2018-02-12

4.  High susceptibility, viral dynamics and persistence of South American Zika virus in New World monkey species.

Authors:  Neil Berry; Deborah Ferguson; Claire Ham; Jo Hall; Adrian Jenkins; Elaine Giles; Dhruti Devshi; Sarah Kempster; Nicola Rose; Stuart Dowall; Martin Fritzsche; Thomas Bleazard; Roger Hewson; Neil Almond
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

5.  Increased rates of Guillain-Barré syndrome associated with Zika virus outbreak in the Salvador metropolitan area, Brazil.

Authors:  Ashley R Styczynski; Juliane M A S Malta; Elisabeth R Krow-Lucal; Jadher Percio; Martha E Nóbrega; Alexander Vargas; Tatiana M Lanzieri; Priscila L Leite; J Erin Staples; Marc X Fischer; Ann M Powers; Gwong-Jen J Chang; P L Burns; Erin M Borland; Jeremy P Ledermann; Eric C Mossel; Lawrence B Schonberger; Ermias B Belay; Jorge L Salinas; Roberto D Badaro; James J Sejvar; Giovanini E Coelho
Journal:  PLoS Negl Trop Dis       Date:  2017-08-30
  5 in total
  4 in total

Review 1.  The legacy of ZikaPLAN: a transnational research consortium addressing Zika.

Authors:  Annelies Wilder-Smith; Elizabeth B Brickley; Ricardo Arraes de Alencar Ximenes; Demócrito de Barros Miranda-Filho; Celina Maria Turchi Martelli; Tom Solomon; Bart C Jacobs; Carlos A Pardo; Lyda Osorio; Beatriz Parra; Suzannah Lant; Hugh J Willison; Sonja Leonhard; Lance Turtle; Maria Lúcia Brito Ferreira; Rafael Freitas de Oliveira Franca; Louis Lambrechts; Johan Neyts; Suzanne Kaptein; Rosanna Peeling; Deborah Boeras; James Logan; Helen Dolk; Ieda M Orioli; Andreas Neumayr; Trudie Lang; Bonny Baker; Eduardo Massad; Raman Preet
Journal:  Glob Health Action       Date:  2021-10-26       Impact factor: 2.640

2.  Antecedent infections in Guillain-Barré syndrome in endemic areas of arbovirus transmission: A multinational case-control study.

Authors:  Sonja E Leonhard; Cheng Yin Tan; Annemiek A van der Eijk; Ricardo R Reisin; Suzanne C Franken; Ruth Huizinga; Samuel Arends; Manou R Batstra; Selma M Bezerra Jeronimo; Judith Drenthen; Laura de Koning; Luciana Leon Cejas; Cintia Marchesoni; Wilson Marques; Nortina Shahrizaila; Dardo F Casas; Andrea Sotelo; Belen Tillard; Mario-Emilio Dourado; Bart C Jacobs
Journal:  J Peripher Nerv Syst       Date:  2021-09-30       Impact factor: 5.188

3.  Arboviral Infections in Neurological Disorders in Hospitalized Patients in São José do Rio Preto, São Paulo, Brazil.

Authors:  Bruno H G A Milhim; Leonardo C da Rocha; Ana C B Terzian; Carolina C P Mazaro; Marcos T Augusto; Adriana Luchs; Nathalia Zini; Livia Sacchetto; Barbara F Dos Santos; Pedro H C Garcia; Rodrigo S Rocha; Elisabete Liso; Vânia M S Brienze; Gislaine C D da Silva; Nikos Vasilakis; Cássia F Estofolete; Maurício L Nogueira
Journal:  Viruses       Date:  2022-07-07       Impact factor: 5.818

4.  Prior Heterologous Flavivirus Exposure Results in Reduced Pathogenesis in a Mouse Model of Zika Virus Infection.

Authors:  James D Brien; Amelia K Pinto; Mariah Hassert; Tara L Steffen; Stephen Scroggins; Abigail K Coleman; Enbal Shacham
Journal:  J Virol       Date:  2021-07-26       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.